Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Zomiradomide

Product Specifications

UNSPSC Description

KT-413 (example I-3) is an orally active PROTAC-class IRAK degrader[1]. KT-413 consists of a target protein ligand (red part) PROTAC IRAK4 ligand-5 (HY-168311), an E3 ubiquitin ligase ligand (blue part) Thalidomide-4-Br (HY-W039116), and a PROTAC linker (black part) 2-(2-Azaspiro[3.3]heptan-6-yl)ethanamine (HY-168313). E3 ubiquitin ligase and linker can form Thalidomide-NH-C2-2-azaspiro[3.3]heptane (HY-168312). The active control for the target protein ligand is RSL3-4-Me (HY-169375).

Target Antigen

IRAK; PROTACs

Type

Reference compound

Related Pathways

Immunology/Inflammation;PROTAC

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/kt-413.html

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(N1C2C(NC(CC2)=O)=O)C3=CC=CC(NCCC(C4)CC4(C5)CN5C[C@H]6CC[C@H](C(SC7=C8)=NC7=CC(C(C)(O)C)=C8NC(C9=CC=CC(C(F)(F)F)=N9)=O)CC6)=C3C1=O

Molecular Weight

871.97

References & Citations

[1]Weiss Matthew M. Preparation of benzothiazole derivatives as IRAK degraders and uses thereof. World Intellectual Property Organization, WO2021127190 A1. 2021-06-24.|[2]Zeng S, et al. Current advances and development strategies of orally bioavailable PROTACs. Eur J Med Chem. 2023 Dec 5;261:115793.

Shipping Conditions

Room Temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-153368/Zomiradomide-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-153368/Zomiradomide-SDS-MedChemExpress.pdf

Clinical Information

Phase 1

CAS Number

2655656-99-6

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MEF2B (Myocyte-specific Enhancer Factor 2B, RSRFR2, Serum Response Factor-like Protein 2, XMEF2, FLJ32599, FLJ46391, MGC189732, MGC189763) (HRP)
MBS6385229-01 0.1 mL

MEF2B (Myocyte-specific Enhancer Factor 2B, RSRFR2, Serum Response Factor-like Protein 2, XMEF2, FLJ32599, FLJ46391, MGC189732, MGC189763) (HRP)

Ask
View Details
MEF2B (Myocyte-specific Enhancer Factor 2B, RSRFR2, Serum Response Factor-like Protein 2, XMEF2, FLJ32599, FLJ46391, MGC189732, MGC189763) (HRP)
MBS6385229-02 5x 0.1 mL

MEF2B (Myocyte-specific Enhancer Factor 2B, RSRFR2, Serum Response Factor-like Protein 2, XMEF2, FLJ32599, FLJ46391, MGC189732, MGC189763) (HRP)

Ask
View Details
CD28 (NM_001243077) Human Tagged ORF Clone
RC231721 10 µg

CD28 (NM_001243077) Human Tagged ORF Clone

Ask
View Details
BRD1 Antibody (N-term)
MBS9205401-01 0.08 mL

BRD1 Antibody (N-term)

Ask
View Details
BRD1 Antibody (N-term)
MBS9205401-02 0.4 mL

BRD1 Antibody (N-term)

Ask
View Details
BRD1 Antibody (N-term)
MBS9205401-03 5x 0.4 mL

BRD1 Antibody (N-term)

Ask
View Details